Evidence map›Paper›PMID 40229419›Full record

ArticleScientific reports2025

Estimation and validation of solubility of recombinant protein in E. coli strains via various advanced machine learning models.

Wael A Mahdi, Adel Alhowyan, Ahmad J Obaidullah

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Wael A MahdiDepartment of Pharmaceutics, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh, 11451, Saudi Arabia.
Adel AlhowyanDepartment of Pharmaceutics, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh, 11451, Saudi Arabia.
Ahmad J ObaidullahDepartment of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh, 11451, Saudi Arabia. aobaidullah@ksu.edu.sa.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study presents a comprehensive approach to predicting solubility of recombinant protein in four E. coli samples by employing machine learning techniques and optimization algorithms. Various models, including AdaBoost, Decision Tree Regression (DT), Gaussian Process Regression (GPR), and K-Nearest Neighbors (KNN) are applied to capture the intricate relationships between experimental factors and protein solubility. The integration of these models within an AdaBoost framework, coupled with advanced hyperparameter tuning via the Firefly Algorithm (FA), demonstrates a novel strategy for improving predictive accuracy and model robustness. Key preprocessing techniques such as Histogram-Based Outlier Detection (HBOD) and Z-score normalization are employed to ensure data integrity and consistency. The Firefly Algorithm (FA), utilizing 5-fold cross-validation as the fitness function, adeptly navigates complex hyperparameter spaces, enhancing model performance across diverse data partitions. The AdaBoost with Gaussian Process Regression (ADA-GPR) model established to be superior to alternatives including ADA-DT and ADA-KNN, demonstrating great performance through high R

Indexed as

Escherichia coliMachine LearningRecombinant ProteinsAlgorithmsSolubilityRecombinant ProteinsDecision tree regressionGaussian process regressionK-Nearest neighborsRecombinant proteinSolubility

Identifiers

PMID40229419
PMCPMC11997140

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.